论文部分内容阅读
1994年6月至1996年5月作者将病理确诊的75例癌症疼痛住院患者随机分成2组：保尔佳加综合治疗的治疗组39例；单用综合治疗的对照组36例，结果表明治疗后的疼痛级数治疗组为4．9±1．1，明显低于对照组5．4±0．8（P＜0．05），而疼痛缓解总有效率治疗组为82．1％，高于对照组55.6％（P＜0．05）。作者认为保尔佳配合癌症的综合治疗，可以明显提高癌痛的缓解率，值得临床研究和应用。
From June 1994 to May 1996, the authors randomly divided 75 patients with pathologically confirmed cancer pain into 2 groups: 39 in the treatment group with Paujia plus comprehensive treatment and 36 in the control group treated with only comprehensive treatment. The results showed that the treatment After treatment, the pain level in the treatment group was 4.9±1.1, which was significantly lower than that in the control group (5.4±0.8) (P<0.05), and the total effective rate of pain relief in the treatment group was 82.1%. Higher than the control group 55.6% (P <0.05). The author believes that Paul Jia Jia with the comprehensive treatment of cancer, can significantly increase the remission rate of cancer pain, worthy of clinical research and application.